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Abstract 
First simple spectrophotometric method was developed and applied to determine Dapagliflozin Propanediol  
Monohydrate by Zero Spectrophotometry and First Derivative Spectrophotometric method for determining of 
Dapagliflozin Propanediol Monohydrate (DAPA) in the presence of Metformin Hydrochloride (MET). Zero 
spectrophotometric (ZS) was applied for the determination of (DAPA) at 223.5 nm. Linearity range was (2.61– 
31.23) µg/mL. Regression analysis showed a good correlation coefficients R2 = 0.9989. The limit of detection 
(LOD) and limit of quantification (LOQ) were to be 0.569 µg/mL and 1.724 µg/mL, respectively. Derivative 
spectrophotometric (1DS) was applied for the determination of (DAPA) in the presence (MET). (DAPA) was 
determined at 233 nm (1D233).  Linearity ranges were (5.21 – 41.64) µg/mL for (DAPA). Regression analysis 
showed a good correlation coefficients R2 = 0.9994. The limit of detection (LOD) and limit of quantification 
(LOQ) were to be 0.732 µg/mL and 2.218 µg/mL for (DAPA). The proposed Zero spectrophotometry method 
was applied to analysis individual (DAPA), and the derivative (1D233) method was applied to analysis (DAPA) 
individually or with (MET) combination in Syrian trademark drugs.  
Keywords: Dapagliflozin Propanediol Monohydrate (DAPA), Metformin Hydrochloride (MET), Zero 
spectrophotometry (ZS), Derivative Spectrophotometry (1DS), Sodium-Glucose Cotransporter 2 (SGLT2). 
Introduction 
Dapagliflozin Propanediol Monohydrate is a crystalline solid, white to half white crystalline powder which is 
insoluble in water and soluble in ethanol, methanol, DMSO, dimethylformamide. It has a formula C24H35ClO9 . 
H2O and molecular weight, 520.985 g/mol. It is inhibiting renal glucose reabsorption through the solid-glucose 
cotransporter (SGLT) offers an insulin-independent alternative to controlling blood glucose concentrations in 
patients with type 2 diabetes. It is a first-generation, selective SGLT inhibitor that blocks glucose transport with 
about 100-fold selective for SGLT2over SGLT11 . 
Dapagliflozin Propanediol Monohydrate is chemically known as (2S)-propane-1,2-diol(2S,3R,5S,6R)-2-{4-
chloro-3-[(4-ethoxy phenyl)methyl]phenyl}-6-(hydroxy methyl)oxane-3-4-5-mono hydrate2,3,4. It is a new class 
of oral antidiabetic drugs; it is also called Sodium Glucose cotransporter 2 (SLGT2) inhibitors. These Sodium 
Glucose Cotransporter are responsible for glucose reabsorption in the kidney. Hence inhibiting the SLGT2 
have been proposed as a new strategy in the treatment of diabetes. By suppressing the SLGT2. Dapagliflozin 
reduces plasma glucose concentration intern by elevating the renal glucose excretion. Dapagliflozin in 
Literature reveals few analytical methods which were reported like UV spectroscopy5, liquid chromatography-
mass spectrometry method in biologicalfluids6, reversed-phase high-performance liquid chromatography (RP-
HPLC) methods7-12 and spectrophotometric methods13 alone or combined with other pharmaceutical drugs. 
Materials and Methods 
Apparatus 
All spectral measurements were carried out using a Spectro Scan 80 DV, UV/Vis spectrophotometer 
instrument Ltd (UK), connected to computer, quartz cells 1 cm. Ultrasonic bath Daihan (China), and stirrer Velp 
Scientifica (Europe). 
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Chemical regents 
Methanol from LOBAL Chemie (India), hydrochloric acid from SURCHEM PRODUCTS LTD (ENGLAND), double 
distilled water. Dapagliflozin Propanediol Monohydrate material, purity 100.2 %, was obtained from Solan 
(Himachal Pradesh) India. Metformin hydrochloride material, purity 99.4 %, was obtained from Switzerland. 
Standard preparation 
Stock standard preparation: Stock solution 2.5 × 10-3 M of Dapagliflozin Propanediol Monohydrate (MW = 
520.985 g/mol) was prepared by dissolving 65.06 mg of Dapagliflozin Propanediol Monohydrate standard 
material in volumetric flask 50 mL of Methanol. The working standard solutions for first method (Zero 
spectrophotometry) were prepared by appropriate dilutions of stock solution 2.5 × 10-3 M with HCl (0.1 N) to 
give concentrations between (2.61 - 31.23) 𝜇g/mL of  Dapagliflozin Propanediol Monohydrate. 
The working standard solutions for the second method (Derivative spectrophotometry) were prepared by 
appropriate dilutions of stock solution 2.5 × 10-3 M with distilled water to give concentrations between (5.21 - 
41.64) 𝜇g/mL of Dapagliflozin Propanediol Monohydrate. 
Calibration Curve 
To construct the calibration curve, five standard Dapagliflozin Propanediol Monohydrate solutions for each 
concentration were prepared and the absorbance was measured of each solution five times. 
Sample preparation 
Two products were studied 
  Zero spectrophotometry 
✓ Ten DapaGold 10 (Golden Med Pharma) tablets were weighed and finely powdered and an accurate 
weight equivalent to one tablet (10 mg), dissolved in 10 mL methanol. The sample solution was filtered 
through a filter paper (Whatman 3, England). Then 0.3 mL was taken to 25 mL volumetric flask and adjusted to 
volume with HCl (0.1 N) to obtain theoretically equivalent to 12 𝜇g/mL. 
✓ Ten DapaGold 5 (Golden Med Pharma) tablets were weighed and finely powdered and an accurate 
weight equivalent to two tablets (5 mg), dissolved in 10 mL methanol. The sample solution was filtered 
through a filter paper (Whatman 3, England). Then 0.3 mL was taken to 25 mL volumetric flask and adjusted to 
volume with HCl (0.1 N), to obtain theoretically equivalent to 12 𝜇g/mL. 
Derivative spectrophotometric: 
✓ Ten Dapa Gold 10 (Golden Med Pharma) tablets were weighed and finely powdered and an accurate 
weight equivalent to one tablet (10 mg), dissolved in 10 mL methanol. The sample solution was filtered 
through a filter paper (Whatman, England). Then 0.2 mL was taken to 25 mL volumetric flask and adjusted to 
volume with distilled water, to obtain theoretically equivalent to 8 𝜇g/mL. 
✓ Ten Dapa Gold 5 ( Golden Med Pharma) tablets were weighed and finely powdered and an accurate 
weight equivalent to two tablets (5 mg), dissolved in 10 mL methanol. The sample solution was filtered 
through a filter paper (Whatman 3, England). Then 0.3 mL was taken to 25 mL volumetric flask and adjusted to 
volume with distilled water, to obtain theoretically equivalent to 12 𝜇g/mL. 
RESULTS AND DISCUSSION 
Zero spectrophotometry: Absorption spectra of the standard raw material samples 10.41 𝜇g/mL (DAPA) and 
9.94 𝜇g/mL (MET) solutions were recorded within a wavelength range of (210 – 300) nm against the blank (all 
the addition constituents without (DAPA) and (MET)). It was noticed, (DAPA) and (MET) cannot be determined 
by direct measurement of absorbance at 223.5 nm, because of the overlapped spectra. 
On the other hand, derivative spectrophotometry showed more resolution, where the determination of (DAPA) 
and (MET) mixture was possible without pretreatment. The first derivative spectrum at zero-crossing point was 
used to determine (DAPA) in the presence of (MET) at 233 nm "Fig. 1". 
Journal of Advances in Chemistry Vol 17 (2020) ISSN: 2321-807X                       https://rajpub.com/index.php/jac 
 82 
 
Fig. 1. First derivative spectra of: a- (DAPA), b- (MET). 
Stability of stock solution: Time effect on  the stability of standard stock solution of Dapagliflozin 
Propanediol Monohydrate in Methanol was studied in three different concentrations 2 × 10-5 M, 3 × 10-5 M and 4 
× 10-5 M. We did not notice any significant changes during the absorption measurement within two months.  
Method’s validation 
The validity and suitability of the proposed method was assessed by linearity (evaluated by regression 
equation), limit of detection (LOD), limit of quantification (LOQ), accuracy (reported as percent %), precision 
(reported as RSD %), robustness, and Sandellʹs sensitivity. 
Linearity 
We studied the linearity of  Dapagliflozin Propanediol Monohydrate standard concentrations at the optimal 
conditions where we made a series of 25 mL of separated volumetric flasks, each one contains variable 
concentrations of Dapagliflozin Propanediol Monohydrate stock solution 2.5 × 10-3 M, and completed  to 25 
mL with HCL (0.1 N). Finally, we measured the absorbance at 223.5 nm for each concentration. "Fig. 2" 
presents the Dapagliflozin Propanediol Monohydrate spectra. The range of linearity was obeyed to Beer’s law 
in concentration (2.61 - 31.23) μg/mL and the linearity curve is presented in      "Fig. 3". 
 
 
 
Journal of Advances in Chemistry Vol 17 (2020) ISSN: 2321-807X                       https://rajpub.com/index.php/jac 
 83 
Fig. 2: spectra of (Dapagliflozin Propanediol .H2O)  
C1: 2.61µg/mL, C2: 5.21 µg/mL, 
C3: 10.42 µg/mL,  C4: 15.63 µg/mL, 
C5: 20.84 µg/mL, C6: 26.05 µg/mL, 
C7: 31.26 µg/mL. 
 
       Fig. 3: (Dapagliflozin Propanediol .H2O) 
           C1: 2.61µg/mL, C2: 5.21 µg/mL,  
           C3: 10.42 µg/mL, C4: 15.63 µg/mL, 
           C5: 20.84 µg/mL, C6: 26.05 µg/mL,  
           C7: 31.26 µg/mL,  n = 5. 
 
The concentration linearity of (DAPA) in presence (MET) was in the range (5.21 - 41.64) 𝜇g/mL at 233 nm by 
1D233 "Figs 4, 5". 
 
Fig. 4: First derivative spectra of 
 (Dapagliflozin Propanediol .H2O): 
C1: 5.21 µg/mL,  C2: 10.41 µg/mL, 
C3: 15.62 µg/mL, C4: 20.82 µg/mL,  
C5: 26.03 µg/mL, C6: 31.23 µg/mL, 
C7: 36.44 µg/mL, C8: 41.64 µg/mL. 
Fig. 5: Calibration curve for 
(Dapagliflozin Propanediol .H2O) 
          C1: 5.21 µg/mL, C2: 10.41 µg/mL,  
          C3: 15.62 µg/mL, C4: 20.82 µg/mL,  
          C5: 26.03 µg/mL, C6: 31.23 µg/mL, 
          C7: 36.44 µg/mL, C8: 41.64 µg/mL. n = 5. 
 
Limit of Detection (LOD) and Limit of Quantification (LOQ) 
In spite of the measurement LOD and LOQ, five concentrations were analyzed in five replicates. LOD and LOQ 
for Dapagliflozin Propanediol Monohydrate  and  Metformin Hydrochloride were calculated by using the 
following equations: 
 
 
 
 
 
Where SD is the standard  deviation of y-intercepts (a) of regression lines and (b) is the slope  of  the  
equitation of calibration curve, y = a + b x and  accuracy results are presented in "table 1". 
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Table 1: Statistical data for calibration curves. 
Method Analyte 
 
Selected 
wavelength 
(nm) 
Linearity 
rang 
𝜇g/mL 
Correlation 
coef. (R2) 
LOD 
𝜇g/mL 
LOQ 
𝜇g/mL 
 
Temperature of 
solution 
ZS DAPA 223.5 2.61 - 31.23 0.9989 0.569 1.724 (25 ± 5) ºC 
1DS DAPA 1D 233 5.21 - 41.64 0.9994 0.732 2.218 
Accuracy 
To determine the precision and accuracy of  the proposed  method,  five  replicate determinations were 
carried out on five different concentrations of standards (Dapagliflozin Propanediol Monohydrate). The 
precision and accuracy results are presented in "table 2". 
Table 2: Accuracy for determination of Dapagliflozin Propanediol Monohydrate. 
Method Material 
Theoretical 
concentration 
(μg/mL) 
 observed 
concentration 
(μg/mL) 
SD 
µg/mL 
Precision 
)RSD %) 
Accuracy 
(%) 
 
 
ZS 
 
Dapagliflozin 
Propanediol 
Monohydrate 
5.21 5.17 0.06 1.16 99.23 
10.42 10.46 0.20 1.91 100.38 
15.62 15.45 0.04 0.26 98.91 
20.82 20.89 0.24 1.15 100.34 
26.03 25.93 0.13 0.50 99.62 
 
 
1DS 
 
Dapagliflozin 
Propanediol 
Monohydrate 
10.41 10.39 0.13 1.25 99.81 
15.62 15.67 0.08 0.51 100.32 
20.82 20.61 0.34 1.65 98.99 
26.03 26.12 0.38 1.45 100.35 
31.23 31.21 0.60 1.92 99.94 
: mean of five replicated determinations, Accuracy (%) = (observed concentration/theoretical concentration) 
× 100, 
Precision (RSD %) = (standard deviation/mean concentration) ˟100. 
 
Precision 
In order to demonstrate the precision of the proposed methods, intra-day and inter-day variability studies 
were performed at three different concentrations for Dapagliflozin Propanediol Monohydrate at the same day 
and also at three different days. Method efficiency was tested in terms of RSD % for both intra-day and inter-
day precision. 
The precision was ascertained by carrying out five replicates of standard Dapagliflozin Propanediol 
Monohydrate under study and the mean was calculated. The RSD% results were not more than 2.47 and 1.94 
for Dapagliflozin Propanediol Monohydrate (ZS) and Dapagliflozin Propanediol Monohydrate (1DS), 
respectively, where the method is considered very precise. 
Robustness 
The robustness of an analytical procedure is a measure of its capacity to maintain unaffected results by a very 
small variation of  some parameters and provides an indication of its reliability during normal usage. The 
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studied variables parameters were slit, scan speed and the wavelength which performed at one concentration 
for Dapagliflozin Propanediol Monohydrate. the results showed no significant differences, "table 3". 
Table 3: Robustness test study. 
Method 
 
Material 
Work 
parameters 
Measured 
deviation 
* 
µg/mL 
RSD 
% 
Percent 
(%) 
ZS 
Dapagliflozin Propanediol 
Monohydrate 
(10.42 µg/mL) 
Slit range 
2 nm 
2 nm 
1 nm 
10.34 
10.36 
0.62 
1.16 
99.23 
99.42 
scan speed 
medium 
Fast 
slow 
10.34 
10.31 
0.62 
0.58 
99.23 
98.94 
Wavelength 
223.5 nm 
+2 nm 
-2 nm 
10.19 
10.16 
0.64 
0.63 
97.79 
97.50 
pH 
0.1 N 
+0.05 
-0.05 
9.99 
10.46 
0.74 
1.86 
95.87 
100.38 
1DS 
Dapagliflozin Propanediol 
Monohydrate 
(15.62 µg/mL) 
Slit range 
2 nm 
2 nm 
1 nm 
15.67 
15.56 
0.52 
1.06 
100.32 
99.62 
scan speed 
medium 
Fast 
slow 
15.67 
15.61 
0.52 
0.96 
100.29 
99.94 
 
Wavelength 
1D233 
+1 nm 
-1 nm 
15.01 
15.31 
0.54 
0.90 
96.09 
98.02 
 
           *n = 5 
Sandell’s sensitivity 
The mean molar absorptivity ε was (27734.82 L/mol.cm)  , Sandell’s sensitivity was (0.038 µg/cm2), were 
calculated from the standard deviation of the absorbance measurements obtained from Beer’s law. 
 
 
RECOVERY 
The recovery was studied by three addition standards for every product. "table 4" presents the recoveries of 
Dapagliflozin Propanediol Monohydrate results for the two products for DapaGold (5,10 mg/tab), Golden Med 
Pharma. 
Table 4: Recoveries of Dapagliflozin Propanediol Monohydrate for (Dapa Gold 5, 10 mg/tab, Golden 
Med Pharma) Syrian products. 
Recovery 
Average 
% 
RSD% 
SD 
µg/mL 
Recovery% 
Total 
Found 
 
µg/mL 
Added 
µg/mL 
Sample 
µg/mL 
Pharmaceutical 
dosage 
Products 
 
Method 
 2.03 2.01 99.23 8.77 3.91 4.89 Dapagliflozin DapaGold 5  
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98.87 
 
0.81 0.80 98.57 9.71 4.89 Propanediol 
Monohydrate 
5 mg/tab 
 
 ZS 
1.68 1.66 98.81 10.69 5.87 
100.29 
2.33 2.36 101.28 8.85 3.91 
4.89 
Dapagliflozin 
Propanediol 
Monohydrate 
5 mg/tab 
 
DapaGold 5 
 
 
 
1DS 
2.92 2.88 98.57 9.71 4.89 
1.83 1.85 101.02 10.82 5.87 
100.24 
2.05 2.06 100.25 17.79 7.90 
9.87 
Dapagliflozin 
Propanediol 
Monohydrate 
10 mg/tab 
 
DapaGold 10 
 
 
ZS 
0.07 0.07 100.81 19.82 9.87 
0.16 0.16 99.66 21.68 11.85 
100.34 
2.95 3.01 102.15 17.94 7.90 
9.87 
Dapagliflozin 
Propanediol 
Monohydrate 
10 mg/tab 
 
 
DapaGold 10 
 
 
1DS 
2.71 2.69 99.29 19.67 9.87 
2.22 2.21 99.58 21.67 11.85 
 
Application: Estimation of Dapagliflozin Propanediol Monohydrate in (DapaGold 5, 10 mg/tab, Golden 
Med Pharma) Syrian tablets products 
The developed method was applied for quantitative determination and identification of Dapagliflozin 
Propanediol Monohydrate in ( DapaGold 5, 10 mg/tab, Golden Med Pharma) Syrian pharmaceutical products. 
The samples were prepared  as described  in the section of samples preparation  and analyzed. Quantitative 
analysis was done by using calibration curve. The obtained results are summarized in "table 5"  for the two 
products. 
The relative standard deviations RSD% (n = 5) were in the range of (0.61 - 1.62)%. Table 5 presents the 
determination results of  Dapagliflozin Propanediol Monohydrate in (DapaGold 5, 10 mg/tab, Golden Med 
Pharma). 
 
Table 5: Results of Dapagliflozin Propanediol Monohydrate (DapaGold 5, 10 mg/tab, Golden Med 
Pharma). 
Method 
DapaGold 5, Golden Med Pharma 
(Dapagliflozin Propanediol Monohydrate 5mg/tab). 
Concentration 
mg/ tab 
SD 
mg/tab 
RSD % Per % 
ZS 5.00 
 
0.08 1.60 100.00 
DS 4.89 
 
0.03 
 
0.61 
 
97.80 
 
Method 
DapaGold10, Golden Med Pharma 
(Dapagliflozin Propanediol Monohydrate 10 mg/tab). 
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Concentration 
 mg/ tab 
SD 
mg/ tab 
RSD % Per % 
ZS 10.09 0.13 
 
1.29 
 
100.90 
 
DS 9.87 
 
0.16 
 
1.62 
 
98.70 
 
                            Mean for five replicates. 
CONCLUSION 
We developed a new method which is suitable for the identification and quantification of Dapagliflozin 
Propanediol Monohydrate in raw material. A good percentage shows that the method can be successfully 
used in routine analyses. The proposed method is simple, sensitive, rapid, specific, a little cost and could be 
applied for quality control of Dapagliflozin Propanediol Monohydrate. The method can be also proposed to 
determine Dapagliflozin Propanediol Monohydrate in pharmaceutical formulations. 
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